Prévisions du marché des tests développés en laboratoire en Europe jusqu’en 2028 – Impact du COVID-19 et analyse régionale par type (biochimie clinique, soins intensifs, hématologie, microbiologie, diagnostics moléculaires, immunologie et autres types de tests) et application (instituts universitaires, organismes de recherche clinique, hôpitaux Laboratoire, centres de diagnostic spécialisés et autres)

Introduction au marché

Un test développé en laboratoire (LDT) est un type de test de diagnostic in vitro conçu et utilisé dans un seul laboratoire. Ces tests peuvent être utilisés pour estimer ou distinguer un vaste assortiment d’analytes tels que des protéines, des composés chimiques comme le glucose ou le cholestérol, ou de l’ADN, à partir d’un échantillon provenant de l’anatomie humaine. L\'expansion des méthodes automatisées de diagnostic in vitro (IVD) pour les laboratoires et les dispensaires afin de fournir des analyses précises et sans erreur devrait alimenter cette augmentation.

Aperçu et dynamique du marché

Le marché européen des tests développés en laboratoire devrait atteindre 8 988,78 millions de dollars américains. d’ici 2028, contre 5 664,43 millions de dollars US en 2021 ; on estime qu\'il augmentera à un TCAC de 6,8 % entre 2021 et 2028. L\'incidence croissante du cancer et des troubles génétiques ainsi que le nombre croissant de lancements de produits à travers l\'Europe sont des facteurs qui propulsent le marché des tests développés en laboratoire. Cependant, l’évolution du paysage réglementaire entrave la croissance du marché des tests de développement en laboratoire.

Les LDT sont développés et utilisés au sein des laboratoires et ne sont pas distribués ou vendus à d\'autres laboratoires ou établissements de santé. Ces tests sont conçus pour surmonter le défi de l’indisponibilité des tests commerciaux. De nombreux LDT sont des tests génétiques développés pour les maladies rares. Ainsi, la fréquence de développement et d\'introduction de nouveaux LDT est élevée. En novembre 2020, Aditx Therapeutics, Inc a reçu une certification CLIA pour les opérations de laboratoire AditxtScore pour la surveillance immunitaire, ce qui leur a permis de lancer le test AditxtScore pour diagnostiquer le COVID-19. L’émergence croissante des variantes du SRAS-CoV-2 a mis en évidence la nécessité d’identifier, de tracer et de suivre les mutations dans l’ensemble du génome viral. En janvier 2021, Eurofins a lancé le test NovaType pour détecter et surveiller les nouvelles variantes du SARS-CoV-2. Ce test RT-PCR est cliniquement validé pour identifier les variantes B.1.1.7 et B.1.351 dans un court laps de temps. NovaType est déjà disponible sous forme de LDT en Allemagne et sera disponible dans plus de 50 laboratoires Eurofins dans le monde pour tester les patients pour le COVID-19. En outre, la demande croissante de médecine personnalisée offre des opportunités de croissance significatives aux acteurs opérant sur le marché européen des tests développés en laboratoire.

Les pays d\'Europe assistent à une résurgence du COVID-19. cas après avoir réussi à atténuer la pandémie. De nombreux pays déclarent chaque jour plus de cas que lors de la première vague de 2020. Les gouvernements de nombreux pays s’efforcent d’augmenter la capacité de test, ce qui stimule davantage le marché des tests développés en laboratoire. De nombreux acteurs du marché ont lancé des produits pour répondre à la demande croissante. Par exemple, en août 2020, Eurofins Technologies (Luxembourg) a lancé une gamme de kits de tests pour la détection sérologique des anticorps par ELISA chez les patients exposés au COVID-19. Ces tests sont conçus pour répondre aux exigences spécifiques à la région concernant le COVID-19. Viracor Eurofins a reçu la Food and Drug Administration (FDA) et l\'autorisation d\'utilisation d\'urgence (EUA) pour son test SARS-CoV-2 développé en laboratoire. D\'autres laboratoires Eurofins ont développé des options alternatives de RT-PCR pour répondre aux obligations réglementaires locales et atténuer les problèmes de chaîne d\'approvisionnement en réactifs à l\'échelle mondiale. Cependant, d\'autres tests non urgents ont connu une baisse en raison des mesures de confinement et de la surcharge des établissements de santé.

Segments clés du marché

Le marché européen des tests développés en laboratoire, par type, est segmenté en biochimie clinique, soins intensifs, hématologie, microbiologie, diagnostic moléculaire, immunologie. , et d\'autres types de tests. Le segment hématologie a été sous-segmenté en coagulation et hémostase, tests d\'hémoglobine, tests de numération globulaire et autres. Le segment du diagnostic moléculaire devrait détenir la plus grande part de marché en 2021. Cependant, le segment de l\'hématologie devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.

Le laboratoire européen a développé Le marché des tests, par application, est segmenté en instituts universitaires, organismes de recherche clinique, laboratoires hospitaliers, centres de diagnostic spécialisés et autres. Le segment des laboratoires hospitaliers devrait détenir la plus grande part de marché en 2021. Cependant, le segment des centres de diagnostic spécialisés devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.

Principales sources et sociétés répertoriées

Quelques-unes les sources primaires et secondaires mentionnées lors de la préparation du rapport sur le marché des tests développés en laboratoire européen sont l\'Association allemande de l\'industrie du diagnostic (VDGH), la Deutsche Akkreditierungsstelle GmbH (DAkkS) et la Fondation espagnole du cœur (FEC).

Raisons d\'acheter le rapport

Déterminer les domaines d\'investissement potentiels sur la base d\'une analyse détaillée des tendances du marché européen des tests développés en laboratoire au cours des prochaines années.
Acquérir une compréhension approfondie des facteurs sous-jacents qui déterminent la demande pour différents segments de thérapies contre la toxicomanie dans les pays les plus dépensiers et identifiez les opportunités offertes par chacun d\'eux.
Renforcez votre connaissance du marché en termes de moteurs de demande, de tendances de l\'industrie et des derniers développements technologiques, entre autres.
Identifier les principaux canaux qui animent le le marché européen du diltiazem, en fournissant une image claire des opportunités futures qui aidera à l\'analyse, ce qui entraînera une augmentation des revenus.
Canaliser les ressources en se concentrant sur les programmes en cours entrepris par les différents pays du Marché des tests développé par un laboratoire européen.

SEGMENTATION DU MARCHÉ DES TESTS DÉVELOPPÉS PAR UN LABORATOIRE EUROPÉEN

Par type

Biochimie clinique
Soins intensifs
Hématologie

- Coagulation et hémostase,
- Test d\'hémoglobine
- Test de numération sanguine
- Autres

Immunologie
Microbiologie
Diagnostic moléculaire
Autres types de tests

Par Application

Instituts universitaires
Organismes de recherche clinique
Laboratoires d\'hôpitaux
Spécialité Centres de diagnostic
Autres

Par pays

Profils d\'entreprise

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Laboratory Developed Test Market – By Type

1.3.2 Europe Laboratory Developed Test Market – By Application

1.3.3 Europe Laboratory Developed Test Market – By Country

2. Laboratory Developed Test Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Laboratory Developed Test Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Experts Opinion

5. Laboratory Developed Test Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidence of Cancer and Genetic Disorders

5.1.2 Large Number of Product Launches

5.2 Market Restraints

5.2.1 Changing Regulatory Landscape

5.3 Market Opportunities

5.3.1 Continuous Research on Personalized Medicine

5.4 Future Trends

5.4.1 Automation of Laboratory Processes

5.5 Impact Analysis

6. Laboratory Developed Test Market –Europe Analysis

6.1 Europe Laboratory Developed Test Market Revenue Forecast and Analysis

7. Laboratory Developed Test Market Analysis – By Type

7.1 Overview

7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

7.3 Clinical Biochemistry

7.3.1 Overview

7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Haematology

7.4.1 Overview

7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Coagulation and Hemostasis

7.4.3.1 Overview

7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Hemoglobin Testing

7.4.4.1 Overview

7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Blood Count Testing

7.4.5.1 Overview

7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6 Others

7.4.6.1 Overview

7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Immunology

7.5.1 Overview

7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Critical Care

7.6.1 Overview

7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Microbiology

7.7.1 Overview

7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Molecular Diagnostics

7.8.1 Overview

7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Other Test Types

7.9.1 Overview

7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8. Laboratory Developed Test Market Analysis – By Application

8.1 Overview

8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

8.3 Academic Institutes

8.3.1 Overview

8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Clinical Research organizations

8.4.1 Overview

8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Hospital laboratory

8.5.1 Overview

8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Specialty Diagnostic Centers

8.6.1 Overview

8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

9. Laboratory Developed Test Market – Europe Analysis

9.1 Europe: Laboratory Developed Test Market

9.1.1 Overview

9.1.3 Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

9.1.3.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.2 Germany: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.1.2.1 Germany: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.1.3 Germany: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.2 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.2 France: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.2.2.1 France: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.2.3 France: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.3 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.1 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.2 UK: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.3.2.1 UK: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.3.3 UK: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.4 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.1 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.2 Italy: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.4.2.1 Italy: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.4.3 Italy: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.5 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.1 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.2 Spain: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.5.2.1 Spain: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.5.3 Spain: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.6 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.1 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.2 Rest of Europe: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.6.2.1 Rest of Europe: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.6.3 Rest of Europe: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Laboratory Developed Test Market

10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Laboratory Developed Test Market–Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Quest Diagnostics Incorporated

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F.HOFFMANN-LA ROCHE LTD.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 QIAGEN

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Illumina, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Eurofins Scientific

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.7 Guardant Health

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 2. Germany Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. France: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 5. France Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 6. France: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 7. UK: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 8. UK Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 9. UK: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10. Italy: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Italy Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 12. Italy: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 13. Spain: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Spain Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 15. Spain: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Rest of Europe: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of Europe Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of Europe: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market

Table 20. Recent Organic Growth Strategies in the Laboratory Developed Test Market

Table 21. Glossary of Terms, Laboratory Developed Test Market

LIST OF FIGURES

Figure 1. Laboratory Developed Test Market Segmentation

Figure 2. Laboratory Developed Test Market Segmentation, By Country

Figure 3. Europe Laboratory Developed Test Market Overview

Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market

Figure 5. Europe Laboratory Developed Test Market – Leading Country Markets (US$ Million)

Figure 6. Europe and PEST Analysis

Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints

Figure 2. Europe Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028

Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)

Figure 22. Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

Figure 23. Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 24. France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 26. Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 27. Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe laboratory developed test market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample